Clinical Trial Update: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluated convalescent plasma for Ebola Virus Disease in Guinea; status completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Hemorrhagic Fever, Ebola | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-07-01